Amanote Research
Register
Sign In
A Review of Samidorphan: A Novel Opioid Antagonist
Cureus
doi 10.7759/cureus.5139
Full Text
Open PDF
Abstract
Available in
full text
Date
July 15, 2019
Authors
Amna Mohyud Din Chaudhary
Manal F Khan
Sukhbir S Dhillon
Sadiq Naveed
Publisher
Cureus, Inc.
Related search
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Fentanyl - A Potent Opioid Analgesic: A Review
Journal of Developing Drugs
EPI-X4, a Novel Endogenous Antagonist of CXCR4
Oncotarget
Oncology
The “Opioid Square”: A Novel Educational Tool for Making Opioid Conversions
Journal of Pain and Symptom Management
Neurology
Anesthesiology
Pain Medicine
Nursing
Opioid System Modulation With Buprenorphine/Samidorphan Combination for Major Depressive Disorder: Two Randomized Controlled Studies
Molecular Psychiatry
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
Computational Opioid Prescribing: A Novel Application of Clinical Pharmacokinetics
Journal of Pain and Palliative Care Pharmacotherapy
Anesthesiology
Pain Medicine
Pharmacology
Properties of a Wine Yeast Antagonist, Saccharomyces Cerevisiae T206. A Review
South African Journal of Enology & Viticulture
Identification and Inhibitory Properties of a Novel Ca2+/Calmodulin Antagonist
Biochemistry
Biochemistry
Naltrindole, a Delta Opioid Antagonist, Reduces Addicting Phenylisopropylamines' Enhancement of Pressing for Rewarding Brain Stimulation
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology